C-RET Antibody / RET
The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney. Alterations in RET gene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease.
Product Specifications
CAS Number
9007-83-4
Specifications
Immunohistochemistry (FFPE) : 1-2 µg/mL
UniProt
P07949
Host
Mouse
Reactivity
Human
Immunogen
A recombinant human partial protein (amino acids 702-848) was used as the immunogen for this RET antibody.
Clonality
Monoclonal
Isotype
IgG1 k
Clone
RET/2795
Applications
IHC-P
Purity
Protein G affinity chromatography
Format
Purified
Buffer
0.2 mg/ml with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reconstitution
Store the c-RET antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Limitations
This c-RET antibody is available for research use only.
Storage Conditions
Store the c-RET antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide) .
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05% sodium azide
Applications Notes
Optimal dilution of the c-RET antibody should be determined by the researcher.
Location
Cytoplasmic, nuclear, cell surface
Image Legend
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD68 (Macrophage Marker) (rLAMP4/824), CF640R conjugate, 0.1mg/mL
CD11b / MAC-1 (Microglial Marker) (ITGAM/3340), CF405S conjugate, 0.1mg/mL
